<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">In aggregate, after we have collectively mourned our dead relatives, our siblings, our elders and perhaps esteemed colleagues of ours, we must urge decision makers to engage preparedness plans that include all needs, of which transfusion and use of plasma derived medicinal products. Scientific societies should raise lobbyist actions towards public health services to make sure that preparedness plans are not moved out second line for many possible reasons. Times will likely change and so will behaviors. What will not change will be the still need of blood components for patients.</p>
